Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Teexs Paramedic drugs > Group 2 > Flashcards

Group 2 Flashcards

You may prefer our related Brainscape-certified flashcards:
NREMT® EMT flashcards NREMT® Paramedic flashcards
1
Q

Amyl Nitrite

Class

A

Antidote, cyanide poisoning adjunct, nitrate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Amyl Nitrite

Mechanism of Action

A

Converts hemoglobin to methemoglobin, which reacts with cyanide and chemically binds with it, preventing any toxic effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Amyl Nitrite

Indications

A

Cyanide poisoning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Amyl Nitrite

Contraindications

A

none in emergency setting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Amyl Nitrite

Adverse reactions/side effects

A
  • Headache, dizziness, weakness, increased ICP, shortness of breath, orthostatic hypotension, tachycardia, syncope.
  • Cyanosis of the lips, fingernails, or palms (signs of methemoglobinemia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Amyl Nitrite

Drug Interactions

A

Increased hypotensive effects with antihypertensives, alcohol ingestion, phenothiazines, or beta-blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Amyl Nitrite

Dosage and administration

A
  • Adult: 1 to 2 ampules crushed and inhaled for 30 seconds of each minute until sodium nitrite is prepared or administer for 30 to 60 seconds every 5 minutes until patient is conscious.
  • Pediatric: 1 ampule crushed and inhaled for 30 seconds of each minute until sodium nitrite is prepared or for 30 to 60 seconds of each minute until sodium nitrite is prepared or administer for 30 to 60 seconds every 5 minutes until patient is conscious.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Amyl Nitrite

Duration of Action

A
  • Oset: 30 seconds to 5 minutes
  • Peak effect: Varies
  • Duration 5 to 10 minutes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Amyl nitrite

Special Considerations

A

-Pregnancy safety: Category X
-May cause fetal harm by reducing maternal BP and
decreasing placental blood supply.
-Highly Flammable: Avoid exposure heat or flame.
-Patient should remain seated or supine during and after administration due to hypotension.
-This is the first step in a three-step treatment for cyanide poisoning followed by sodium nitrite and then sodium thiosulfate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Aspirin (acetylsalicylic Acid [ASA])

Class

A

Platelet inhibitor, anti-inflammatory agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Aspirin (acetylsalicylic Acid [ASA])

Mechanism of Action

A

-Prevents the formation of thromboxane A2, which causes platelets to clump together (aggregate) and form plugs that cause obstruction or constriction; has antipyretic and analgesic properties

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Aspirin (acetylsalicylic Acid [ASA])

indications

A

-New onset chest discomfort suggestive of ACS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Aspirin (acetylsalicylic Acid [ASA])

Contraindications

A

Hypersensitivity

-Relatively contraindicated in patients with active ulcer disease or asthma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Aspirin (acetylsalicylic Acid [ASA])

Adverse reactions/side effects

A

Bronchospasm, anaphylaxis, wheezing in allergic patients, prolonged bleeding, GI bleeding, epigastric distress, nausea, vomiting, heartburn, Reye syndrome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Aspirin (acetylsalicylic Acid [ASA])

Drug interactions

A

Use with caution on patients allergic to NSAIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Aspirin (acetylsalicylic Acid [ASA])

Dosage and administration

A
  • Adult: 160 mg to 325 mg PO. Chewed

- Pediatric: Not recommended

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Aspirin (acetylsalicylic Acid [ASA])

Duration of action

A
  • Onset: 5 to 30 minutes
  • Peak effect: 1 to 3 hours
  • Duration 3 to 6 hours
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Aspirin (acetylsalicylic Acid [ASA])

Special Considerations

A

Pregnancy safety: Category D
- Use cautiously during pregnancy, weighing risks and benefits. If there are no contraindications, non-enteric- coated, chewable aspirin should be given as soon as possible to all patients with a suspected ACS as soon as possible after symptom onset.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Vasopressin (Pitressin)

Class

A

Vasopressor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Vasopressin (Pitressin)

Mechanism of Action

A

Stimulation of smooth muscle receptors; potent vasoconstrictor when given in high doses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Vasopressin (Pitressin)

indications

A

Vasodilatory shock

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Vasopressin (Pitressin)

Contraindications

A

Use with caution in patients with:

  • CAD
  • Epilepsy
  • Heart failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Vasopressin (Pitressin)

Adverse reactions/side effects

A

Dizziness, headache, bronchial constriction, MI, Chest pain, angina, cardiac dysrhythmia, decreased cardiac output, abdominal cramps, diarrhea, nausea, vomiting , paleness, sweating.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Vasopressin (Pitressin)

Drug Interactions

A

None Reported

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Vasopressin (Pitressin)

Dosage and administration

A
  • Adult: 0.02 to 0.07 unit/min IV infusion

- Pediatric: Safety and efficacy not established

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Vasopressin (Pitressin)

Duration of action

A
  • Onset: Unknown
  • Peak effect: Unknown
  • Duration: 30 to 60 minutes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Vasopressin (Pitressin)

Special Considerations

A
  • Pregnancy Safety: Category C
  • Use caution during pregnancy. Breastfeeding women should pump and discard breast milk for 1.5 hours after drug administration.
  • May increase peripheral Vascular resistance and provoke cardiac ischemia and angina.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Nalbuphine Hydrochloride (Nubain)

Class

A

Synthetic opioid Agonist/antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Nalbuphine Hydrochloride (Nubain)

Mechanism of action

A
  • Activates opiate receptor in limbic system of the CNS.
  • Analgesic, similar to morphine on a milligram-for-milligram basis
  • Both agonist and antagonist properties
  • Preferred for chest pain in setting of acute MI because it reduces the myocardial oxygen demand without reducing the BP.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Nalbuphine Hydrochloride (Nubain)

Indications

A

Chest pain associated with AMI moderate to severe acute pain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Nalbuphine Hydrochloride (Nubain)

Contraindications

A
  • Head Injury
  • Undiagnosed abdominal pain, diarrhea caused by poison.
  • Hypovolemia, hypotension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Nalbuphine Hydrochloride (Nubain)

Adverse reactions/side effects

A

Headache, dizziness, vertigo, seizure

  • CNS depression, paradoxical CNS stimulation, respiratory depression, pulmonary edema.
  • Hypotension, hypertension, palpitations, bradycardia, nausea, vomiting, dry mouth.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Nalbuphine Hydrochloride (Nubain)

Drug Interactions

A

CNS depressants may potentiate effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Nalbuphine Hydrochloride (Nubain)

Dosage and Administration

A
  • Adult: 2 to 5mg slowly IV. May repeat doses PRN to a maximum dose of 10mg
  • Pediatric: NOT RECOMENDED
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Nalbuphine Hydrochloride (Nabain)

Duration of action

A
  • Onset: 2 to 3minutes
  • Peak Effect: Variable
  • Duration: 3 to 6 hours
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Nalbuphine Hydrochloride (Nabain)

Special Considerations

A
  • Pregnancy Safety: Category B
  • Use with caution in patients with impaired respiratory function,
  • May precipitate withdrawal syndromes in narcotic-dependent patients.
  • Naloxone should be readily available
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Norepinephrine Bitartrate (Levophed)

Class

A
  • Sympathomimetic

- Vasopressor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Norepinephrine Bitartrate (Levophed)

Mechanism Of Action

A
  • Potent alpha-agonist resulting in intense peripheral vasoconstriction
  • Positive chronotropic and increased cardiac effect (from 10% beta effect) with increased cardiac output.
  • Alpha-adrenergic activity resulting in peripheral vasoconstriction and beta-adrenergic activity leading to inotropic stimulation of the heart and coronary artery vasodilation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Norepinephrine Bitartrate (Levophed)

Indications

A
  • Cardiogenic shock
  • Unresponsive to fluid resuscitation, significant hypotensive (<70mm Hg) states
  • First-line vasopressor in septic shock.
40
Q

Norepinephrine Bitartrate (Levophed)

Contraindications

A
  • Hypotensive patients with hypovolemia.

- Pregnancy (relative).

41
Q

Norepinephrine Bitartrate (Levophed)

Adverse Reactions/side effects

A
  • Headache, anxiety, dizziness, restlessness
  • Dyspnea, bradycardia, hypertension, dysrhythmias, chest pain, peripheral cyanosis, cardiac arrest.
  • Nausea, vomiting,
  • Urinary retention, renal failure,
  • Decreased blood flow to the GI tract, kidneys, skeletal muscle, and skin, tissue necrosis from extravasation.
42
Q

Norepinephrine Bitartrate (Levophed)

Drug interactions

A
  • Can be deactivated by alkaline solutions.
  • Sympathomimetic and phosphodiesterase inhibitors may exacerbate dysrhythmias.
  • Bretylium may potentiate the effects of catecholamines
43
Q

Norepinephrine Bitartrate (Levophed)

Dosage and administration

A
  • Adult: 0.1 to 0.5 mcg/kg per minute ( in 70-kg adult, 7 to 35 mcg/min)
  • Pediatric: Begin at 0.1 to 2mcg/kg per minute IV infusion, adjust the rate to achieve desired change in BP and systemic perfusion. Titrated to patient response
44
Q

Norepinephrine Bitartrate (Levophed)

Duration of action

A

-Onset: 1 to 3 minutes
Peak effect: Variable

-Duration: 5 to 10 minutes, lasts only 1 minute after infusion discontinued.

45
Q

Norepinephrine Bitartrate (Levophed)

Special considerations

A
  • Pregnancy Safety: Category C.
  • Use cautiously during pregnancy and while breastfeeding. May cause fetal anoxia when used in pregnancy.
  • Infuse norepinephrine through a large, stable vein to avoid extravasation and tissue necrosis. Often used with low-dose DOPamine to spare decreased renal and mesenteric blood flow.
  • Drug or poison-induced hypotension may require higher doses to achieve adequate perfusion.
46
Q

Nitroglycerin (Nitrostat, Nitro-Bid, Tridil)

Class

A

-Vasodilator

47
Q

Nitroglycerin (Nitrostat, Nitro-Bid, Tridil)

Mechanism Of Action

A
  • Smooth muscle relaxant acting on vasculature, bronchial, uterine, intestinal smooth muscle.
  • Dilation of arterioles and veins in the periphery.
  • Reduces preload and afterload, decreasing workload of the heart and thereby myocardial oxygen demand.
48
Q

Nitroglycerin (Nitrostat, Nitro-Bid, Tridil)

Indications

A

Acute angina pectoris, ischemic chest pain, hypertension, heart failure, pulmonary edema.

49
Q

Nitroglycerin (Nitrostat, Nitro-Bid, Tridil)

Contraindications

A

Contraindications Hypotension, hypovolemia, intracranial bleeding or head injury, pericardial tamponade, severe bradycardia or tachycardia, RV infarction, previous administration in the last 24 hours: sildenafil (Viagra) or 48 hours: vardenafil (Levitra) or tadalafil (Cialis).

50
Q

Nitroglycerin (Nitrostat, Nitro-Bid, Tridil)

Adverse reactions/side effects

A
  • Headache, dizziness, weakness,

- Reflex tachycardia, syncope, hypotension, nausea, vomiting,

51
Q

Nitroglycerin (Nitrostat, Nitro-Bid, Tridil)

Drug Interactions

A

Additive effects with other vasodilators. Incompatible with other drugs IV.

52
Q

Nitroglycerin (Nitrostat, Nitro-Bid, Tridil)

Special considerations

A

-Pregnancy safety: Category C.

  • Has been used safely during pregnancy. Use caution with breastfeeding women and monitor infants for adverse effects.
  • Hypotension more common in older patients. If 12-lead ECG shows inferior wall infarct, rule out RV infarction via right-sided 12-lead ECG prior to administering NTG.
  • NTG decomposes when exposed to light or heat, must be kept in airtight containers.
  • Must be administered only with an infusion pump direct from bottle with a vented IV set and non-PVC tubing. Active ingredient may have stinging effect when administered.
53
Q

Naloxone Hydrochloride (Narcan)

Class

A

Opioid antagonist, antidote.

54
Q

Naloxone Hydrochloride (Narcan)

Mechanism of Action

A

Competitive inhibition at narcotic receptor sites. Reverses respiratory depression secondary to opiate drugs. Completely inhibits the effect of morphine.

55
Q

Naloxone Hydrochloride (Narcan)

Indications

A
  • Opiate overdose, complete or partial reversal of CNS and respiratory depression induced by opioids, decreased level of consciousness
  • Coma of unknown origin.
  • Narcotic agonist for the following: morphine sulfate, heroin, HYDROmorphone (Dilaudid), methadone, meperidine (Demerol), paregoric, fentaNYL (Sublimaze), oxycodone (Percodan), codeine, propoxyphene (Darvon).
  • Narcotic agonist and antagonist for the following: butorphanol (Stadol), pentazocine (Talwin), nalbuphine (Nubain).
56
Q

Naloxone Hydrochloride (Narcan)

Contraindications

A

Use with caution in narcotic-dependent patients. Use with caution in neonates of narcotic-addicted mothers.

57
Q

Naloxone Hydrochloride (Narcan)

Adverse Reactions/side effects

A

Restlessness, seizures, dyspnea, pulmonary edema, tachycardia, hypertension, dysrhythmias, cardiac arrest, nausea, vomiting, withdrawal symptoms in opioid-addicted patients, diaphoresis.

58
Q

Naloxone Hydrochloride (Narcan)

Drug interaactions

A

Incompatible with bisulfite and alkaline solutions.

59
Q

Naloxone Hydrochloride (Narcan)

Dosage and Administration

A

-Adult: 0.4 to 2 mg IM/IV/IO/subcutaneous/ET/IN (diluted); minimum single dose recommended: 2 mg. Repeat at 5-minute intervals to a maximum total dose of 10 mg (medical control may request higher amounts). For IN route, administer half the dose in each nostril; maximum dose is 1 mL per nostril.

60
Q

Naloxone Hydrochloride (Narcan)

Duration of Action

A
  • Onset: Less than 2 minutes.
  • Peak effect: Variable.
  • Duration: 30 to 60 minutes.
61
Q

Naloxone Hydrochloride (Narcan)

Special Considerations

A

Pregnancy safety: Category C. Any use during pregnancy. Use in breastfeeding women should be clearly indicated.

  • Assist ventilations prior to administration to avoid sympathetic stimulation. Seizures without causal relationship have been reported.
  • May not reverse hypotension. Use caution when administering to narcotic addicts (potential violent behavior).
  • Half-life of naloxone is often shorter than the half-life of narcotics; repeat dosing may be required.
  • In cardiac arrest, naloxone is generally not beneficial.
62
Q

Morphine Sulfate (Roxanol, MS Contin)

Class

A

Opioid analgesic; schedule II drug.

63
Q

Morphine Sulfate (Roxanol, MS Contin)

Mechanism of Action

A

Alleviates pain through CNS action. Suppresses fear and anxiety centers in the brain. Depresses brainstem respiratory centers. Increases peripheral venous capacitance and decreases venous return. Decreases preload and afterload, which decreases myocardial oxygen demand.

64
Q

Morphine Sulfate (Roxanol, MS Contin)

Indications

A

Severe heart failure, acute cardiogenic pulmonary edema.

-Chest pain associated with AMI, analgesia for moderate to severe acute and chronic pain.

65
Q

Morphine Sulfate (Roxanol, MS Contin)

Contraindication

A

Head injury, exacerbated COPD, depressed respiratory drive, hypotension.

  • Undiagnosed abdominal pain, decreased level of consciousness,
  • Suspected hypovolemia.
  • Patients who have taken MAOIs within 14 days.
66
Q

Morphine Sulfate (Roxanol, MS Contin)

Adverse reactions/side effects

A
  • Confusion, sedation, headache,
  • CNS depression, respiratory depression, apnea, bronchospasm, dyspnea,
  • Hypotension, orthostatic hypotension, syncope, bradycardia, tachycardia, nausea, vomiting, dry mouth.
67
Q

Morphine Sulfate (Roxanol, MS Contin)

Drug Interactions

A

Potentiates sedative effects of phenothiazines. CNS depressants may potentiate effects of morphine. MAOIs may cause paradoxical excitation.

68
Q

Morphine Sulfate (Roxanol, MS Contin)

Dosage and Administration

A
  • Adult: STEMI: Initial dose: 2 to 4 mg slow IV (over 1 to 5 minutes).
    - Repeat dose: 2 to 8 mg at 5 to 15 minute intervals. NSTEMI/unstable angina: 1 to 5 mg IV push if symptoms not relieved by nitrates, use with caution.

-Pediatric: 0.1 to 0.2 mg/kg per dose IV, IO, IM, subcutaneous. Maximum dose: 5 mg.

69
Q

Morphine Sulfate (Roxanol, MS Contin)

Duration of Action

A
  • Onset: Immediate.
  • Peak effect: 20 minutes.
  • Duration: 2 to 7 hours.
70
Q

Morphine Sulfate (Roxanol, MS Contin)

Special Considerations

A

Pregnancy safety: Category C. Use caution weighing risks and benefits during pregnancy. Use cautiously in breastfeeding women. Morphine rapidly crosses the placenta. Safety in neonates has not been established.

  • Use with caution in older patients, those with asthma, and in those susceptible to CNS depression.
  • Vagotonic effect in patients with acute inferior MI (bradycardia, heart block). Naloxone hydrochloride (Narcan) should be readily available as an antidote.
71
Q

Atropine Sulfate

Class

A

Anticholinergic agent.

72
Q

Atropine Sulfate

Mechanism of Action

A

Inhibits the action of acetylcholine at postganglionic parasympathetic neuroeffector sites. Increases heart rate in symptomatic bradydysrhythmias. Indications Hemodynamically unstable

73
Q

Atropine Sulfate

Indications

A

Hemodynamically unstable bradycardia, organophosphate poisoning, nerve agent exposure, RSI in pediatrics, beta-blocker or calcium channel blocker overdose.

74
Q

Atropine Sulfate

Contraindications

A

Tachycardia, hypersensitivity, unstable cardiovascular status in acute hemorrhage with myocardial ischemia, narrowangle glaucoma, hypothermic bradycardia.

75
Q

Atropine Sulfate

Adverse Reactions/side effects

A

Drowsiness, confusion, headache, tachycardia, palpitations, dysrhythmias, nausea, vomiting, pupil dilation, dry mouth/nose/skin, blurred vision, urinary retention, constipation, flushed, hot, dry skin; paradoxical bradycardia when pushed too slowly or when given at low doses.

76
Q

Atropine Sulfate

Drug Interactions

A

Potential adverse effects when administered with digitalis, cholinergics, physostigmine. Effects enhanced by antihistamines, procainamide, quinidine, antipsychotics, benzodiazepines, and antidepressants.

77
Q

Atropine Sulfate

Dosage and Administration

A
  • Adult: Unstable bradycardia: 0.5 mg IV/IO every 3 to 5 minutes as needed; maximum total dose 3 mg total. Use shorter dosing interval (3 minutes) and higher doses in severe clinical conditions. Organophosphate poisoning: Extremely large doses (2 to 4 mg or higher) may be needed.
  • Pediatric: Unstable bradycardia: 0.02 mg/kg IV/IO (minimum dose: 0.1 mg). May repeat once. Maximum single dose: Child: 0.5 mg. Adolescent: 1 mg. Maximum total dose: Child: 1 mg. Adolescent: 3 mg. ET dose: 0.04 to 0.06 mg/kg.
78
Q

Atropine Sulfate

Duration of action

A
  • Onset: Immediate.
  • Peak effect: 2 to 4 minutes.
  • Duration: 4 to 6 hours.
79
Q

Atropine Sulfate

Special Considerations

A
  • Pregnancy safety: Category C.
  • Moderate doses may cause pupillary dilation. Paradoxical bradycardia can occur with doses lower than 0.1 mg. May be ineffective in patients who have had a heart transplant or in infranodal AV blocks.
80
Q

DOPamine Hydrochloride (Intropin)

Class

A

Adrenergic, vasopressor, inotropic agent.

81
Q

DOPamine Hydrochloride (Intropin)

Mechanism of Action

A
  • Immediate metabolic precursor to norepinephrine.
  • Produces positive inotropic and chronotropic effects. Constricts systemic vasculature, increasing BP and preload. Increases myocardial contractility and stroke volume.
82
Q

DOPamine Hydrochloride (Intropin)

Indications

A

Cardiogenic and septic shock, hypotension with low cardiac output states, distributive shock, second-line drug for symptomatic bradycardia.

83
Q

DOPamine hydrochloride (Intropin)

Contraindications

A

Hypersensitivity, hypovolemic shock, pheochromocytoma, uncorrected tachydysrhythmias, VF.

84
Q

DOPamine hydrochloride (Intropin)

Adverse reactions/side effects

A

Extravasation may cause tissue necrosis. Headache, anxiety, dyspnea, dysrhythmias, hypotension, hypertension, palpitations, chest pain, increased myocardial oxygen demand, nausea, vomiting.

85
Q

DOPamine hydrochloride (Intropin)

Drug Interactions

A

Incompatible with alkaline solutions (sodium bicarbonate). MAOIs will enhance the effect of DOPamine. When administered with phenytoin, may cause hypotension, bradycardia, and seizures.

86
Q

DOPamine hydrochloride (Intropin)

Dosage and administration

A
  • Adult: IV/IO infusion at 5 to 20 mcg/kg per minute, slowly titrated to patient response.
  • Pediatric: IV/IO infusion at 5 to 20 mcg/kg per minute, slowly titrated to patient response.
87
Q

DOPamine hydrochloride (Intropin)

Duration of action

A
  • Onset: 1 to 4 minutes.
  • Peak effect: 5 to 10 minutes.
  • Duration: Effects cease almost immediately after infusion is discontinued.
88
Q

DOPamine hydrochloride (Intropin)

Special Considrations

A

Pregnancy safety: Category C.

-Use caution with pregnant and breastfeeding women.

  • Effects are dosedependent.
  • Beta-adrenergic response: 5 to 10 mcg/kg per minute: positive chronotropic and inotropic effects.

-Alpha-adrenergic response: 10 to 20 mcg/kg per minute: vasoconstriction and increase in BP. Greater than 20 mcg/kg per minute: alpha effects predominate and may compromise circulation in the limbs. Should be administered by infusion pump.

89
Q

EPINEPHrine (Adrenalin)

Class

A

Sympathomimetic

90
Q

EPINEPHrine (Adrenalin)

Mechanism of action

A

Direct-acting alpha and beta agonist.

  • Alpha: vasoconstriction.
  • Beta-1: positive inotropic, chronotropic, and dromotropic effects.
  • Beta-2: bronchial smooth muscle relaxation and dilation of skeletal vasculature. Blocks histamine receptors.
91
Q

EPINEPHrine (Adrenalin)

Indications

A

Cardiac arrest (asystole, PEA, VF, and pulseless VT), symptomatic bradycardia as an alternative infusion to DOPamine, hypotension from shock other than hypovolemia, allergic reaction, anaphylaxis, asthma.

92
Q

EPINEPHrine (Adrenalin)

Contraindications

A

None in the emergency setting.

-Relative contraindications include hypertension, hypothermia, pulmonary edema, myocardial ischemia, hypovolemic shock.

93
Q

EPINEPHrine (Adrenalin)

Adverse Reactions/Side effects

A

Nervousness, restlessness, headache, tremor, pulmonary edema, dysrhythmias, chest pain, hypertension, tachycardia, nausea, vomiting.

94
Q

EPINEPHrine (Adrenalin)

Drug Interactions

A

Potentiates other sympathomimetics.

-Deactivated by alkaline solutions. MAOIs may potentiate effect. Beta-blockers may blunt effects.

95
Q

EPINEPHrine (Adrenalin)

Dosage and administration

A

Adult:

  • Allergic reactions and asthma: 0.3 to 0.5 mg (0.3 to 0.5 mL of 1 mg/mL [1:1,000]) IM.
  • Cardiac arrest: IV/IO: 1 mg (10 mL of 0.1 mg/mL [1:10,000 solution]) 3 to 5 minutes during resuscitation. Follow each dose with a 20-mL flush and elevate arm for 10 to 20 seconds after dose. ET: 2 to 2.5 mg diluted in 10 mL normal saline.
  • Continuous infusion: Add 1 mg to 250 mL normal saline or 5% dextrose in water (D5W; 4 mcg/mL).
  • Profound bradycardia or hypotension: 2 to 10 mcg/min titrated to patient response. Higher dose: up to 0.2 mg/kg may be used for specific indications, such as beta-blocker or calcium channel blocker overdose.

-Pediatric: Anaphylaxis/severe status asthmaticus: 0.01 mg/kg (0.01 mL/kg) IM of a 1 mg/mL (1:1,000) solution (maximum single dose: 0.3 mg).

  • Cardiac arrest: IV/IO dose: 0.01 mg/kg (0.1 mL/kg) of a 0.1-mg/mL (1:10,000) solution every 3 to 5 minutes during arrest.
  • ET: 0.1 mg/kg (0.1 mL/kg) of a 1-mg/mL (1:1,000) solution mixed in 3 to 5 mL of saline until IV/IO access is achieved. Maximum single dose 1 mg IV/IO 2.5 mg ET.
  • Stridor at rest: 0.25 to 0.5 mg/kg of a 1-mg/mL (1:1,000) solution (maximum of 5 mg per dose); this can be diluted with normal saline to bring the volume to 3 mL. Administer l-EPINEPHrine via handheld nebulizer.
  • Symptomatic bradycardia: IV/IO: 0.01 mg/kg (0.1 mL/kg) of a 0.1-mg/mL (1:10,000) solution. ET: 0.1 mg/kg (0.1 mL/kg) of a 1-mg/mL (1:1,000) solution.22 Continuous IV/IO infusion: 0.1 to 1 mcg/kg per minute.22

-Neonates:
Bradycardia: 0.01 to 0.03 mg/kg of 0.1 mg/mL (1:10,000) EPINEPHrine (equal to 0.1 to 0.3 mL/kg) IV, followed by 0.5-mL to 1-mL normal saline flush to clear the line; 0.05 to 0.1 mg/kg of 0.1 mg/mL (1:10,000) ET until IV access can be obtained, but absorption is less reliable via this route. If IV access is not yet established, consider starting with the higher dose of 0.3 up to 1 mL/kg of 0.1 mg/mL (1:10,000) EPINEPHrine given via the ET tube. Dosing may be repeated every 3 to 5 minutes when there is persistent bradycardia.

96
Q

EPINEPHrine (Adrenalin)

Duration of action

A

Onset: Immediate.

Peak effect: Minutes.

Duration: Several minutes.

97
Q

EPINEPHrine (Adrenalin)

Special Considerations

A

Pregnancy safety: Category C. Contraindicated for patients in active labor. May cause syncope in asthmatic children. May increase myocardial oxygen demand.

Teexs Paramedic drugs (1 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions